RTX Corporation (RTX)
NYSE: RTX · Real-Time Price · USD
156.81
-0.76 (-0.48%)
At close: Aug 1, 2025, 4:00 PM
156.92
+0.11 (0.07%)
After-hours: Aug 1, 2025, 7:59 PM EDT
ShockWave Medical Stock Forecast
Stock Price Forecast
The 13 analysts that cover ShockWave Medical stock have a consensus rating of "Buy" and an average price target of $160.85, which forecasts a 2.58% increase in the stock price over the next year. The lowest target is $126 and the highest is $182.
Price Target: $160.85 (+2.58%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ShockWave Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Buy | 5 | 6 | 6 | 6 | 6 | 7 |
| Hold | 4 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $130 → $153 | Hold | Maintains | $130 → $153 | -2.43% | Jul 29, 2025 |
| UBS | UBS | Strong Buy Maintains $166 → $177 | Strong Buy | Maintains | $166 → $177 | +12.88% | Jul 23, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $145 → $175 | Buy | Maintains | $145 → $175 | +11.60% | Jul 23, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $165 → $170 | Buy | Maintains | $165 → $170 | +8.41% | Jul 23, 2025 |
| Susquehanna | Susquehanna | Buy Maintains $160 → $175 | Buy | Maintains | $160 → $175 | +11.60% | Jul 23, 2025 |
Financial Forecast
Revenue This Year
86.48B
from 80.74B
Increased by 7.11%
Revenue Next Year
91.59B
from 86.48B
Increased by 5.92%
EPS This Year
6.00
from 3.55
Increased by 68.96%
EPS Next Year
6.75
from 6.00
Increased by 12.59%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 90.7B | 96.9B | 104.0B |
| Avg | 86.5B | 91.6B | 96.9B |
| Low | 83.4B | 87.7B | 92.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 12.3% | 12.0% | 13.5% |
| Avg | 7.1% | 5.9% | 5.8% |
| Low | 3.3% | 1.4% | 0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.46 | 7.54 | 8.58 |
| Avg | 6.00 | 6.75 | 7.48 |
| Low | 5.53 | 6.06 | 6.32 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 81.9% | 25.7% | 27.0% |
| Avg | 69.0% | 12.6% | 10.8% |
| Low | 55.7% | 1.0% | -6.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.